CTRI/2020/03/023787已完成4 期
A Prospective, Open-label, Non-comparative, Multi-centric Active PMS to evaluateefficacy and safety of STOMAFIT ORAL LIQUID containing Liquor Bismuth Ammonium Citrate2.5ml, Belladonna Dry Extract 9mg, Thymol 0.15mg and Menthol 0.2 mg in Gastritis orGastroesophageal Reflux Disease (GERD)
SUNCARE FORMULATIONS PVT LTD0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Male and female subjects 18-60 years of age
- •2. Patients having gastrointestinal illness; signs and symptoms confirmed from clinical judgement
- •3. Patients willing to give informed consent for the Active PMS and willing to comply with all the study procedure and requiremnets
排除标准
- •1. History of HIV positive patients
- •2. Chronic heart failure, respiratory failure or chronic liver and renal failure.
- •3. Patient with active cancer.
- •4. Female who is pregnant, planning a pregnancy (during the course of the study) or nursing a child
- •5. Certain medications that may interfere with the study medication (these will be identified by the study Investigator).
研究者
相似试验
尚未招募
4 期
A clinical study to evaluate the safety and efficacy of Tropicamide, Phenylephrine and Lidocaine injection in patients undergoing lens replacement surgery.CTRI/2024/01/062038Appasamy Ocular Devices (P) Ltd.
尚未招募
4 期
Active PMS study to Evaluate the Safety, Tolerability and Efficacy of FDC of Epalrestat 150 mg plus Pregabalin 150 mg Bilayered Sustained Release Tablets in Adult Patients for the treatment of pain due to Diabetic Peripheral NeuropathyCTRI/2020/09/027557Aeon Formulations Pvt Ltd
已完成
4 期
Study to evaluate the efficacy, safety and tolerability of fixed dose combination [FDC] Voglibose 0.3mg + Metformin (SR ) 500mg in treatment of patients with Type II diabetesCTRI/2011/06/001846Abbott Healthcare Private Limited110
进行中（未招募）
不适用
Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children.Severe Respiratory Syncytial Virus Infection (RSV)MedDRA version: 17.1Level: PTClassification code 10061603Term: Respiratory syncytial virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-004527-42-Outside-EU/EEAAbbott Laboratories LLC100
暂停
不适用
Clinical Study to Evaluate the Efficacy and Safety of Ayurvedic Medicine Rasnalasoona for Cervical Spondylosis in Adults.CTRI/2016/05/006954Dhathri Ayurveda Private Limited40